NKMax America logo

NKMax America Funding & Investors

Santa Ana, CA

NKMax America is harnessing the power of the body's immune system through the development of unique Natural Killer (NK) cell therapies. NK cell adoptive immunotherapy enhances a patient's ability to destroy abnormal cells. The mission of NKMax is to improve patients'​ lives in a safe and natural way through innovative cell therapy products and to ultimately become the global leader in immune cell therapeutics. More information can be found on our website www.nkmaxamerica.com

nkmaxamerica.com

Total Amount Raised: $16,000,000

NKMax America Funding Rounds

  • Post Ipo Debt

    $5,000,000

  • IPO

    Unknown

  • Seed

    $11,000,000

    Seed Investors

    Gaingels
Funding info provided by Diffbot.